[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403-455-7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 64, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2023, "totalPay": 278694, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 155018, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2023, "totalPay": 202191, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 60, "title": "Consultant of Clinical Operations", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.05, "open": 1.03, "dayLow": 1.005, "dayHigh": 1.0399, "regularMarketPreviousClose": 1.05, "regularMarketOpen": 1.03, "regularMarketDayLow": 1.005, "regularMarketDayHigh": 1.0399, "payoutRatio": 0.0, "beta": 0.166, "forwardPE": -0.60479045, "volume": 33513, "regularMarketVolume": 33513, "averageVolume": 55201, "averageVolume10days": 112360, "averageDailyVolume10Day": 112360, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 3826132, "fiftyTwoWeekLow": 0.802, "fiftyTwoWeekHigh": 3.13, "fiftyDayAverage": 0.9562, "twoHundredDayAverage": 1.29761, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1391264, "profitMargins": 0.0, "floatShares": 3305586, "sharesOutstanding": 3788250, "sharesShort": 31452, "sharesShortPriorMonth": 24840, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.03507, "heldPercentInstitutions": 0.07575, "shortRatio": 1.91, "shortPercentOfFloat": 0.0085, "impliedSharesOutstanding": 3819160, "bookValue": 0.958, "priceToBook": 1.0542797, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "earningsQuarterlyGrowth": -0.955, "netIncomeToCommon": -3313346, "trailingEps": -1.15, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.54, "52WeekChange": -0.61886793, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 1.01, "targetHighPrice": 14.496235, "targetLowPrice": 14.496235, "targetMeanPrice": 14.496235, "targetMedianPrice": 14.496235, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 2473649, "totalCashPerShare": 0.653, "ebitda": -2577996, "totalDebt": 38785, "quickRatio": 3.287, "currentRatio": 3.531, "debtToEquity": 1.162, "returnOnAssets": -0.34206, "returnOnEquity": -0.83055997, "freeCashflow": -1111743, "operatingCashflow": -3678648, "earningsGrowth": -0.972, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketPrice": 1.04, "postMarketChange": 0.03, "regularMarketChange": -0.03999996, "regularMarketDayRange": "1.005 - 1.0399", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 55201, "fiftyTwoWeekLowChange": 0.208, "fiftyTwoWeekLowChangePercent": 0.25935164, "fiftyTwoWeekRange": "0.802 - 3.13", "fiftyTwoWeekHighChange": -2.1200001, "fiftyTwoWeekHighChangePercent": -0.6773163, "fiftyTwoWeekChangePercent": -61.886795, "earningsTimestamp": 1743451200, "earningsTimestampStart": 1747252800, "earningsTimestampEnd": 1747684800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.15, "epsForward": -1.67, "epsCurrentYear": -1.574, "priceEpsCurrentYear": -0.64167726, "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "corporateActions": [], "postMarketTime": 1746219242, "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": 2.97029, "fiftyDayAverageChange": 0.053799987, "fiftyDayAverageChangePercent": 0.056264367, "twoHundredDayAverageChange": -0.28761005, "twoHundredDayAverageChangePercent": -0.22164598, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "cryptoTradeable": false, "regularMarketChangePercent": -3.8095202, "regularMarketPrice": 1.01, "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]